Patients with infection-related hospitalization may have increased risk for incident heart failure, including HFrEF and HFpEF.

Tenax Therapeutics progresses levosimendan for PH-HFpEF with Phase 3 trials, aiming for a first-of-its-kind therapy. Click ...

Dapagliflozin reduced the risk of death or worsening heart failure in older patients with aortic stenosis who underwent transcatheter aortic-valve implantation.

Brain aging may lead to a decline in immune system response and hinder the removal of aged cells. The accumulation of these ...

Affinity Health, a leading provider of high-quality health cover, offers essential guidance on when to seek medical help if ...